MINNEAPOLIS, September 16, 2024--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Steve Tipler as a managing director in the ...

Piper Sandler has reiterated its Overweight rating on Wolverine World Wide (NYSE: NYSE:WWW) with a consistent price target of $18.00. The firm's confidence in the company is buoyed by strong brand ...

Piper Sandler has maintained a positive outlook on Immunic Inc. (NASDAQ: NASDAQ:IMUX), reiterating an Overweight rating with a price target of $28.00. The firm's stance is based on the potential ...

Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Immunic (IMUX – Research Report) today and set a price target of $28.00. The company’s shares closed last Friday at $1.52.

In a report released today, Joseph Catanzaro from Piper Sandler maintained a Buy rating on Context Therapeutics (CNTX – Research Report), with a price target of $4.50. The company’s shares ...

In all, 167 men died when a gas leak set off explosions that ripped apart the Piper Alpha platform 120 miles off the Aberdeenshire coast in July 1988. Those left behind say the 'catastrophic ...

After hours: September 18 at 6:22 PM EDT ...

Piper Sandler has reaffirmed its Overweight rating on shares of Context Therapeutics (NASDAQ: CNTX) with a consistent price target of $4.50. The firm's confidence is bolstered by recent data presented ...

Piper Sandler has recently reduced Iovance Biotherapeutics Inc (IOVA) stock to Neutral rating, as announced on July 29, 2024, according to Finviz. Earlier, on November 20, 2023, Goldman had initiated ...